GlassScriptPhysician profile
Mohammed A Tabbaa
NPI 1851736151
$1,741.49
in general payments reported to CMS, 2019-2025
23 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $118 · 2021: $162 · 2022: $194 · 2023: $362 · 2024: $304 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,017.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $328.63 | 2022-2025 | Veozah |
| Hologic Sales and Service, LLC | $208.69 | 2020-2025 | Aptima, Thinprep 2000 Processor, Affirm Prone Biopsy System |
| Abbvie INC. | $182.57 | 2019-2021 | |
| Organon LLC | $165.40 | 2021-2025 | Nexplanon, Nuvaring |
| Exeltis, USA INC. | $144.90 | 2020-2025 | Slynd |
| Sage Therapeutics, LLC | $133.26 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $103.67 | 2021-2023 | |
| Agile Therapeutics, INC. | $59.21 | 2023-2024 | Twirla |
| Allergan, INC. | $58.25 | 2019 | |
| Coopersurgical, INC. | $51.06 | 2021-2025 | Summit Doppler, Paragard T 380a |
| Myovant Sciences INC. | $45.17 | 2021 | |
| Shield Therapeutics INC | $40.44 | 2023-2025 | Accrufer |
| Roche Diagnostics Corporation | $36.57 | 2019 | |
| Merck Sharp & Dohme LLC | $30.50 | 2019-2020 | |
| Lupin INC. | $25.12 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $22.08 | 2024 | |
| Therapeuticsmd, INC. | $22.06 | 2019 | |
| Meditrina | $18.29 | 2023 | |
| Optumhealth Care Solutions, LLC | $18.27 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Pacira Pharmaceuticals Incorporated | $12.87 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.14 | 2019 | |
| Pfizer INC. | $11.82 | 2022 | |
| Ethicon US, LLC | $10.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Tabbaa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.